Expertise in
3
conditions

Beodeul Y. Kang

Songnam, KR 
Expertise in
3
conditions
Songnam, KR 

Overview

Beodeul Kang practices practicing medicine in Songnam, Republic of Korea.

Kang is highly rated in 3 conditions, according to our data. Their clinical expertise encompasses Cholangiocarcinoma (Bile Duct Cancer), Liver Cancer, Delirium, Tissue Biopsy, and Splenectomy.

They are actively involved in clinical research, co-authoring 111 peer reviewed articles and participating in 1 clinical trial.

Locations

Songnam, Republic of Korea
Other Locations
Goyang, Republic of Korea
Gyeonggi-do, Republic of Korea
Seoul, Republic of Korea
Gwangju, Republic of Korea
Republic of Korea
Amorepacific Corporation R&D Center, Yongin, 446729, Republic of Korea

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

A Randomized, Multicenter, Phase 3 Study of Zanidatamab in Combination With Chemotherapy With or Without Tislelizumab in Subjects With HER2-positive Unresectable Locally Advanced or Metastatic Gastroesophageal Adenocarcinoma (GEA)
A Randomized, Multicenter, Phase 3 Study of Zanidatamab in Combination With Chemotherapy With or Without Tislelizumab in Subjects With HER2-positive Unresectable Locally Advanced or Metastatic Gastroesophageal Adenocarcinoma (GEA)
Enrollment Status: Active_not_recruiting
Publish Date: September 01, 2026
Intervention Type: Drug
Study Drugs: Zanidatamab, Tislelizumab, Trastuzumab, Capecitabine, Oxaliplatin, Cisplatin, 5-Fluorouracil
Study Phase: Phase 3

111 Total Publications

EP4 Antagonist ONO-4578 Plus Nivolumab and Chemotherapy in Human Epidermal Growth Factor Receptor 2-Negative Unresectable Advanced or Recurrent Gastric or Gastroesophageal Junction Cancer.
EP4 Antagonist ONO-4578 Plus Nivolumab and Chemotherapy in Human Epidermal Growth Factor Receptor 2-Negative Unresectable Advanced or Recurrent Gastric or Gastroesophageal Junction Cancer.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: June 01, 2026

Frequently Asked Questions about Beodeul Y. Kang

Is Beodeul Y. Kang a top-rated expert for Cholangiocarcinoma (Bile Duct Cancer)?

MediFind is an objective health platform that identifies experts based on real-world data. Beodeul Y. Kang is classified as an Advanced expert for Cholangiocarcinoma (Bile Duct Cancer), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Beodeul Y. Kang participate in research or clinical trials?

Yes. Beodeul Y. Kang has published 111 articles and abstracts on conditions like Cholangiocarcinoma (Bile Duct Cancer). You can view a list of Beodeul Y. Kang's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Kang's expertise for a condition
ConditionClose
      View All 11 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile